Verastem, Inc. VSTM
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2011-11-08
Verastem, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Paterson Dan | President and CEO | 2026-06-22 | Sell | 20,871 | $4.18 |
| Calkins Daniel | Chief Financial Officer | 2026-06-22 | Sell | 4,032 | $4.18 |
| Calkins Daniel | Chief Financial Officer | 2026-06-22 | Sell | 57 | $4.13 |
| BAILEY MICHAEL P | director | 2026-05-21 | Grant | 108,000 | — |
| Tollefson Karin Anna | director | 2026-05-21 | Grant | 36,000 | — |
| Stuglik Brian M | director | 2026-05-21 | Grant | 36,000 | — |
| Rowinsky Eric K | director | 2026-05-21 | Grant | 36,000 | — |
| ROBERTSON MICHELLE | director | 2026-05-21 | Grant | 36,000 | — |
Source: SEC EDGAR filings · CIK 0001526119 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.